Venture capital firm

Lilly Asia Ventures

Biomedical venture capital firm investing in drug, device and diagnostics companies from offices in Asia and California

Visit Website Get introducedRequest an introduction Write a Review

TrustList summary

Lilly Asia Ventures, known as LAV, is a biomedical venture capital firm. It says it wants to be a long-term partner for entrepreneurs building companies that develop products to treat disease and improve health.

Products and services

Biopharmaceutical investment: funding for drug developers.
Human therapeutics: companies working on treatments.
Medical devices: device makers.
Diagnostics: companies building tests and diagnostic tools.

Clients

Entrepreneurs seeking patient, long-term capital and scientific rigour. The firm describes its philosophy as backing people, products and quality science, and combines domain expertise with a global network.

Key facts

Offices: Shanghai, Hong Kong and Palo Alto
Focus: biomedical ventures

Summary written by TrustList from the business's own published information, Oct 2026.

Gallery

1 image - click to enlarge

Categories & features

Rankings

Lilly Asia Ventures is ranked on 2 TrustList rankings: #27 on 1 and #50 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Lilly Asia Ventures has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 2 rankings

#27of 45
Shanghai
It is one of 3 here listing medical.
Its profile: “- Offices: Shanghai, Hong Kong and Palo Alto - Focus: biomedical ventures Lilly Asia Ventures, known as LAV, is a biomedical venture capital firm.”
Of the 45 here, 6 also cover healthtech and 5 also cover banking; 25 also work in Hong Kong and 14 also work in New York City.
Behind Kairon Labs, ahead of LYZZ Capital.
#50of 69
Hong kong
It is one of 4 here listing medical.
Its profile: “- Offices: Shanghai, Hong Kong and Palo Alto - Focus: biomedical ventures Lilly Asia Ventures, known as LAV, is a biomedical venture capital firm.”
Of the top 59 here, 10 also cover partners and 6 also cover fintech; 24 also work in London and 21 also work in Shanghai.
Behind Jebsen Capital.

As of 2026-11-01. Organic ranks only; sponsored placements are never ranks. How TrustList ranks

Ask TrustList to introduce you to Lilly Asia Ventures

Reviews

Write the first review of Lilly Asia Ventures

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Lilly Asia Ventures.